acebutolol has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heo, CY; Jeong, JH; Lee, S; Myung, Y; Park, JK | 1 |
| Alves da Cunha, MA; Barbosa, AM; Barroso, RR; Dekker, RF; Fonseca, EA; Fortes, ZB; Ivanov, RC; Khaper, N; Marques, PT; Turmina, JA | 1 |
2 other study(ies) available for acebutolol and Breast Neoplasms
| Article | Year |
|---|---|
The effect of immediate postoperative intravenous administration of ferric carboxymaltose after autologous free-flap breast reconstruction.
Topics: Administration, Intravenous; Breast Neoplasms; Female; Ferric Compounds; Humans; Maltose; Mammaplasty; Postoperative Complications; Retrospective Studies | 2022 |
Lasiodiplodan, an exocellular (1→6)-β-D: -glucan from Lasiodiplodia theobromae MMPI: production on glucose, fermentation kinetics, rheology and anti-proliferative activity.
Topics: Ascomycota; Biomass; Bioreactors; Breast Neoplasms; Cell Proliferation; Fermentation; Glucans; Glucose; Humans; Kinetics; Maltose; MCF-7 Cells; Nitrogen; Rheology; Sucrose | 2012 |